Carcinoma intraductal de próstata concomitante y respuesta al tratamiento hormonal en el carcinoma de próstata metastásico
Tài liệu tham khảo
Culp, 2020, Recent global patterns in prostate cancer incidence and mortality rates, Eur Urol., 77, 38, 10.1016/j.eururo.2019.08.005
Cetin, 2010, Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program, Urology., 75, 1396, 10.1016/j.urology.2009.07.1360
Cózar, 2013, Registro Nacional de cáncer de próstata 2010 en España, Actas Urol Esp., 37, 12, 10.1016/j.acuro.2012.06.006
Andriole, 2009, Mortality results from a randomized prostate-cancer screening trial, N Engl J Med., 360, 1310, 10.1056/NEJMoa0810696
Schröder, 2009, Screening and prostate-cancer mortality in a randomized European study, N Engl J Med., 360, 1320, 10.1056/NEJMoa0810084
Guo, 2006, Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance, Mod Pathol., 19, 1528, 10.1038/modpathol.3800702
Cohen, 2000, Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: significance for cancer progression, Prostate., 43, 11, 10.1002/(SICI)1097-0045(20000401)43:1<11::AID-PROS3>3.0.CO;2-B
Robinson, 2010, Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings, J Urol., 184, 1328, 10.1016/j.juro.2010.06.017
Kovi, 1985, Ductal spread in prostatic carcinoma, Cancer., 56, 1566, 10.1002/1097-0142(19851001)56:7<1566::AID-CNCR2820560717>3.0.CO;2-Y
Shah, 2010, Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies, Am J Surg Pathol., 34, 470, 10.1097/PAS.0b013e3181cfc44b
Dawkins, 2000, Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression, Prostate., 44, 265, 10.1002/1097-0045(20000901)44:4<265::AID-PROS1>3.0.CO;2-I
Kimura, 2014, Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens, Prostate., 74, 680, 10.1002/pros.22786
Pagliarulo, 2012, Contemporary role of androgen deprivation therapy for prostate cáncer, Eur Urol., 61, 11, 10.1016/j.eururo.2011.08.026
Mottet N. EAU guidelines on prostate cancer 2020. http://uroweb.org/wp-content/uploads/EAU-Guidelines-Prostate-Cancer-2020.pdf
Zhao, 2017, The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy, Oncotarget., 8
Gandaglia, 2015, Impact of the site of metastases on survival in patients with metastatic prostate cancer, Eur Urol., 68, 325, 10.1016/j.eururo.2014.07.020
McNeal, 1996, Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations, Am J Surg Pathol., 20, 802, 10.1097/00000478-199607000-00003
Eisenhauer, 2009, New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer., 45, 228, 10.1016/j.ejca.2008.10.026
Epstein, 2016, The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system, Am J Surg Pathol., 40, 244, 10.1097/PAS.0000000000000530
Humphrey, 2016, The 2016 WHO Classification of tumours of the urinary system and male genital organs-Part B: prostate and bladder tumours, Eur Urol., 70, 106, 10.1016/j.eururo.2016.02.028
Porter, 2017, Systematic review links the prevalence of intraductal carcinoma of the prostate to prostate cancer risk categories, Eur Urol., 72, 492, 10.1016/j.eururo.2017.03.013
Saeter, 2017, Intraductal carcinoma of the prostate on diagnostic needle biopsy predicts prostate cancer mortality: a population-based study, Prostate., 77, 859, 10.1002/pros.23326
Dinerman, 2017, Population-based study of the incidence and survival for intraductal carcinoma of the prostate, Urol Oncol., 35, 673, 10.1016/j.urolonc.2017.08.015
Zhao, 2015, Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer?, Prostate., 75, 225, 10.1002/pros.22906
Chen, 2015, The presence and clinical implication of intraductal carcinoma of the prostate in CPRC patients, Prostate., 75, 1247, 10.1002/pros.23005
Yamamoto, 2017, Effect of chemotherapy on survival for intraductal carcinoma of the prostate (IDC-P) in patients with castration-resistant prostate cancer, J Clin Oncol., 35, 10.1200/JCO.2017.35.6_suppl.e601
Sweeney, 2015, Chemohormonal therapy in metastatic hormone-sensitive prostate cancer, N Engl J Med., 373, 737, 10.1056/NEJMoa1503747
Fizazi, 2017, Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer, N Engl J Med., 377, 352, 10.1056/NEJMoa1704174